Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1981-12-21
1983-12-06
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A61K 3116
Patent
active
044193653
ABSTRACT:
The present invention provides a method of treating Alzheimer's disease, which method comprises administering to a person requiring such treatment, a pharmaceutically acceptable acid addition salt of deferoxamine USAN. Such salts are preferably administered parenterally in the form of aqueous solutions. The dosage of suitable acid addition salts of deferoxamine, e.g. of the mesylate, is conveniently from about 0.2 to 5 g daily, preferably from about 0.2 to 1.5 g and in particular about 0.5 to about 1.0 g daily, especially twice daily 0.5 g, depending on the individual condition of the patient and the stage of the disease.
REFERENCES:
Crapper et al., Science, vol. 180, pp. 511-513 (1973).
Crapper et al., Brain, vol. 99, pp. 67-80 (1976).
Pekl et al., Science, vol. 208, pp. 297-299 (1980).
McDermott et al., The Lancet, pp. 710-711 (Oct. 1, 1977).
Crapper et al., Brain Research, vol. 97, pp. 253-264 (1975).
Crapper et al., The Aging Brain and Senile Dementia, pp. 229-246 (1977).
Ackrill et al., The Lancet, pp. 692-693 (9/27/80).
Yunice et al., Arch. Environ. Health, pp. 163-170 (vol. 16-2/68).
Krishnan et al., Canadian Journal of Spectroscopy, vol. 21, No. 1, (Jan./Feb. 1976).
Muller, Conf. Proceed. St. Louis; Senile Dementia, pp. 237-250 (3/22-23/1978.
Crapper et al., Aging, vol. 7, pp. 471-485 (1978).
Trapp et al., Biological Psychiatry, vol. 13, No. 6, pp. 709-718 (1978).
Alfrey et al., New Eng. Jour. Med., vol. 294, No. 4, pp. 184-188 (1/22/76).
Ciba-Geigy Corporation
Friedman Stanley J.
Glynn Michael W.
LandOfFree
Method of treating Alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating Alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating Alzheimer's disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2029689